BioNtech: Through COVID-19, a Global Vaccine from Marburg, Germany
BioNTech’s new universal COVID-19 vaccine candidate, developed in Marburg, Germany, has entered Phase III trials this week, marking a potential breakthrough in pandemic preparedness. Unlike prior mRNA vaccines targeting specific ... Read More